This transcript has been edited for clarity. Michael Wechsler, MD: Hello. I'm Dr Mike Wechsler and welcome to Medscape's InDiscussion series on moderate to severe asthma. This is episode three of the ...

Asthma is a chronic inflammatory condition marked by an imbalance in the immune response within the airways. According to Lancet, asthma affects around 339 million people globally. While conventional ...

A study has shown that severe asthma can be controlled using biologic therapies, without the addition of regular high-dose inhaled steroids, which can have significant side effects. The findings from ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. We are really fortunate to be managing ...

Researchers have found that the inclusion of a third drug to commonly used dual-drug inhalers can reduce asthma exacerbations and improve control over the disease in children, adolescents, and adults ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this author to personalize your feed and get ...

Asthma is an umbrella diagnosis covering a number of heterogeneous inflammatory pathways. In the past, excessive T-helper cell type 2 (Th2) response and immunoglobulin E (IgE) sensitivity were thought ...

A peak flow meter is a simple, small, hand-held tool that can help you maintain control of asthma by providing a measurement of how well air moves out of the lungs. After blowing into the device, the ...

Chimeric antigen receptor (CAR) T cell therapy has been shown to be hugely advantageous in the treatment of cancers. This therapy employs genetically modified T-cells to find and destroy cancers. Now, ...

Please provide your email address to receive an email when new articles are posted on . 42.6% of patients filled a SABA prescription 30 days before an exacerbation, and 61.4% did so within 30 days ...

Researchers have found that the inclusion of a third drug to commonly used dual-drug inhalers can reduce asthma exacerbations and improve control over the disease in children, adolescents, and adults ...